Recipients
Helen Nichol
Bill Roesler
Saskatchewan has metastatic cancer rates above the national average and one of the highest prevalences of multiple sclerosis (MS). The Gene Expression Mapping Using Synchrotron Light (GEMS) Research Group is developing and applying hard x-ray technologies to advance synchrotron-based health research.
Over the past seven years, synchrotron experts, clinicians and biomedical researchers conceived GEMS technology and worked together to build and test its potential on the newly commissioned BMIT beamline. Under the leadership of Dr. Helen Nichol, they are expanding their scope to include pivotal studies on MS that will be carried out at the Biological X-ray Absorption Spectroscopy (BioXAS) beamlines.
The long-term objective of the group is to research metastatic lung cancer and MS by interacting with the growing network of researchers using a wide variety of synchrotron techniques available and under development at the Canadian Light Source (CLS).
